4/A//SEC Filing
REED JOHN C 4/A
Accession 0000200406-24-000098
CIK 0000200406other
Filed
Oct 30, 8:00 PM ET
Accepted
Oct 31, 5:57 PM ET
Size
8.8 KB
Accession
0000200406-24-000098
Insider Transaction Report
Form 4/AAmended
REED JOHN C
EVP, Innovative Medicine, R&D
Transactions
- Tax Payment
Common Stock
2024-05-01$144.59/sh−10,984$1,588,177→ 14,577 total - Exercise/Conversion
Restricted Share Units
2024-05-01−25,255→ 50,510 total→ Common Stock (25,255 underlying) - Exercise/Conversion
Common Stock
2024-05-01+25,255→ 25,561 total
Footnotes (2)
- [F1]The Restricted Share Units awarded on May 1, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting.
- [F2]Shares withheld for payment of taxes upon vesting of Restricted Share Units.
Documents
Issuer
JOHNSON & JOHNSON
CIK 0000200406
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001181561
Filing Metadata
- Form type
- 4/A
- Filed
- Oct 30, 8:00 PM ET
- Accepted
- Oct 31, 5:57 PM ET
- Size
- 8.8 KB